StreetInsider.com News Articles

Form SCHEDULE 13G BIODESIX INC Filed by: Soleus Capital Master Fund, L.P.

Thu, 18 Jun 2026 17:01:00 -0400

si-local-file:///var/storage/secattach/20260618/26667085.html

Form SCHEDULE 13G BIODESIX INC Filed by: Soleus Capital Master Fund, L.P.

Thu, 18 Jun 2026 17:01:00 -0400

si-local-file:///var/storage/secattach/20260618/26667085.html

Biodesix (BDSX) PT Raised to $27 at Canaccord

Thu, 18 Jun 2026 06:57:13 -0400

(Updated - June 18, 2026 6:57 AM EDT)

Canaccord analyst Kyle Mikson raised the price target on Biodesix (NASDAQ: BDSX) to $27.00 (from $22.00) while maintaining a Buy rating.

The analyst commented: "We reiterate our BUY rating on Biodesix (BDSX) shares and raise our price target to $27 from $22. This week, we were fortunate to host investor meetings with BDSX's management team, including Scott Hutton, CEO, Robin Harper Cowie, Chief Financial Officer, and Kieran O'Kane, CCO. Investors were interested in BDSX's sales force hiring as well as increasing emphasis on PCPs. That said, management is committed to capital conservation. Moreover, investors

Biodesix (BDSX) PT Raised to $27 at Canaccord

Thu, 18 Jun 2026 06:57:13 -0400

(Updated - June 18, 2026 6:57 AM EDT)

Canaccord analyst Kyle Mikson raised the price target on Biodesix (NASDAQ: BDSX) to $27.00 (from $22.00) while maintaining a Buy rating.

H.C. Wainwright Starts Biodesix (BDSX) at Buy

Mon, 15 Jun 2026 06:14:04 -0400

H.C. Wainwright analyst Yi Chen initiates coverage on Biodesix (NASDAQ: BDSX) with a Buy rating and a price target of $26.00.

For an analyst ratings summary and ratings history on Biodesix click here. For more ratings news on Biodesix click here.

Shares of Biodesix closed at $15.06 yesterday.

Form EFFECT BIODESIX INC

Mon, 01 Jun 2026 06:07:00 -0400

si-local-file:///var/storage/secattach/20260601/26578470.html

Form EFFECT BIODESIX INC

Mon, 01 Jun 2026 06:07:00 -0400

si-local-file:///var/storage/secattach/20260601/26578470.html

Form 424B3 BIODESIX INC

Mon, 01 Jun 2026 06:00:00 -0400

si-local-file:///var/storage/secattach/20260601/26578187.html

Form 424B3 BIODESIX INC

Mon, 01 Jun 2026 06:00:00 -0400

si-local-file:///var/storage/secattach/20260601/26578187.html

Form S-3 BIODESIX INC

Thu, 21 May 2026 16:39:00 -0400

si-local-file:///var/storage/secattach/20260521/26536134.html

Form S-3 BIODESIX INC

Thu, 21 May 2026 16:39:00 -0400

si-local-file:///var/storage/secattach/20260521/26536134.html

Biodesix to Participate in Upcoming Investor Conferences

Thu, 21 May 2026 06:00:00 -0400

LOUISVILLE, Colo., May 21, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics solutions company, today announced that members of the Biodesix leadership team will participate in three upcoming investor conferences:

Craig-Hallum 23^rd Annual Institutional Investor Conference
1x1 meetings only
Date: Thursday, May 28, 2026
Location: Minneapolis, MN

William Blair 46^th Annual Growth Stock Conference
Presentation and 1x1 meetings
Presentation Date and Time: Wednesday, June 3, 2026 at 2:00 PM CT
Location: Chicago, IL

TD Cowen Annual Tools/Dx Revolution
1x1 meetings only
Date: Wednesday, June 24, 2026
Location: Dana Point,

Biodesix to Participate in Upcoming Investor Conferences

Thu, 21 May 2026 06:00:00 -0400

Craig-Hallum 23^rd Annual Institutional Investor Conference
1x1 meetings only
Date: Thursday, May 28, 2026
Location: Minneapolis, MN

William Blair 46^th Annual Growth Stock Conference
Presentation and 1x1 meetings
Presentation Date and Time: Wednesday, June 3, 2026 at 2:00 PM CT
Location: Chicago, IL

TD Cowen Annual Tools/Dx Revolution
1x1 meetings only
Date: Wednesday, June 24, 2026
Location: Dana Point,

Form 8-K BIODESIX INC For: May 19

Wed, 20 May 2026 16:19:00 -0400

si-local-file:///var/storage/secattach/20260520/26528651.html

Form 8-K BIODESIX INC For: May 19

Wed, 20 May 2026 16:19:00 -0400

si-local-file:///var/storage/secattach/20260520/26528651.html

Form SCHEDULE 13G/A BIODESIX INC Filed by: PERCEPTIVE ADVISORS LLC

Fri, 15 May 2026 16:00:00 -0400

si-local-file:///var/storage/secattach/20260515/26504580.html

Form SCHEDULE 13G/A BIODESIX INC Filed by: PERCEPTIVE ADVISORS LLC

Fri, 15 May 2026 16:00:00 -0400

si-local-file:///var/storage/secattach/20260515/26504580.html

Biodesix Announces ATS 2026 Presentations Providing Real-World Clinical Evidence and Healthcare System Economic Value for Nodify Lung® Testing Strategy